undefined
EUTM file information

018433786

Amniotics


March 18, 2021

Trademark Summary

The trademark application Amniotics was filed by Amniotics AB, a corporation established under the laws of the Kingdom of Sweden (the "Applicant"). The application was published for oppositions on April 7, 2021, and it was registered by office on July 15, 2021 without any oppositions.

The application was filed in English (French was selected as the second language).

Change of name and professional address of the trademark registration was recorded on June 14, 2022.


Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Pharmaceutical and medical preparations
    2. Pharmaceutical preparations containing stem cells
    3. Pharmaceutical preparations derived from stem cells
    4. Pharmaceutical preparations containing stem cells for treating cancer
    5. Pharmaceutical preparations containing stem cells for treating neurological conditions
    6. Pharmaceutical preparations containing stem cells for treating immunological conditions
    7. Pharmaceutical preparations containing stem cells for treating renal conditions
    8. Pharmaceutical preparations containing stem cells for treating wounds
    9. Pharmaceutical preparations containing stem cells for treating dermatological conditions
    10. Pharmaceutical preparations containing stem cells for treating respiratory conditions
    11. Pharmaceutical preparations containing stem cells for treating coronaviruses conditions
    12. Stem cells
    13. Stem cells for medical purposes
    14. Stem cells for prevention and treatment of respiratory diseases
    15. Stem cells for prevention and treatment of coronaviruses
    16. Stem cells for prevention and treatment of cancer
    17. Stem cells for prevention and treatment of neurological conditions
    18. Stem cells for prevention and treatment of immunological conditions
    19. Stem cells for prevention and treatment of renal diseases
    20. Stem cells for prevention and treatment of wounds
    21. Stem cells for prevention and treatment of dermatological conditions
    22. Human allograft tissue
    23. Surgical implants grown from stem cells [living tissues]
    24. Surgical implants comprised of living tissues for guided tissue regeneration
    25. Surgical implants comprised of living tissues
    26. Tissue-regenerative pharmaceutical preparations
    27. Gauze
    28. Medical dressings, coverings and applicators
    29. All the aforementioned goods not being related to veterinary purposes.
  • The mark was filed in class 10 with following description of goods:
    1. Surgical, medical, and dental apparatus and instruments
    2. Therapeutic and assistive devices adapted for the disabled
    3. Diagnostic apparatus for medical purposes
    4. Surgical, medical, and dental apparatus and instruments, including syringes, needles, cannulas, tubes, connectors, filters, cocks, valves, filters, strainers, containers, collection bags for fluids, as well as combinations of the aforesaid goods for the use in diagnostic and surgical interventions
    5. Surgical implants made of artificial materials.
  • The mark was filed in class 42 with following description of goods:
    1. Scientific and technological services and research and design relating thereto
    2. Research and development services
    3. Research and development in the field of microorganisms and cells
    4. Research and development in the field of stem cells
    5. Research and development services in the field of cell therapy
    6. Research and development services in the field of neurodegenerative diseases
    7. Research and development services in the field of gene expression systems.
  • The mark was filed in class 44 with following description of goods:
    1. Medical diagnostic services (testing and analysis)
    2. Medical testing services relating to the diagnosis and treatment of disease
    3. Medical analysis services for the diagnosis of cancer
    4. Stem cell therapy services
    5. Medical services relating to the removal, treatment and processing of stem cells.